Fractyl Health (GUTS) News Today $1.37 -0.10 (-6.80%) Closing price 10/7/2025 04:00 PM EasternExtended Trading$1.35 -0.02 (-1.46%) As of 06:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GUTS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Fractyl Health announces preclinical results from RJVA-002October 7 at 9:26 PM | msn.comPromising Potential of Fractyl Health’s Innovative Gene Therapy for Obesity Earns Buy RatingOctober 7 at 11:31 AM | tipranks.comFractyl Health, Inc.: Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for ObesityOctober 7 at 8:03 AM | finanznachrichten.deFractyl Health's RJVA-002 Demonstrates ~30% Weight Loss in Preclinical Obesity Model, Highlighting Potential as Next-Generation TherapyOctober 7 at 7:31 AM | quiverquant.comQFractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for ObesityOctober 7 at 7:00 AM | globenewswire.comFractyl Health, Inc. (NASDAQ:GUTS) Short Interest UpdateOctober 6 at 5:59 AM | marketbeat.comFractyl Health Approves Share Issuance in Special MeetingOctober 3, 2025 | tipranks.comFractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Rating of "Buy" from AnalystsOctober 3, 2025 | marketbeat.comPositive Outlook on Fractyl Health’s Revita Procedure Boosts Buy RatingSeptember 29, 2025 | tipranks.comFractyl Health price target raised to $5 from $4 at BofASeptember 29, 2025 | msn.comFractyl Health (GUTS) Is Up 35.6% After Revita Shows Weight Loss Maintained Post-GLP-1 and $60M RaiseSeptember 29, 2025 | finance.yahoo.comHC Wainwright Cuts Fractyl Health (NASDAQ:GUTS) Price Target to $8.00September 27, 2025 | americanbankingnews.comFractyl Health stock gains after pricing of $60M underwritten offeringSeptember 26, 2025 | msn.comFractyl Health prices 60M shares at $1.00 in underwritten offeringSeptember 26, 2025 | msn.comFractyl Health price target lowered to $8 from $9 at H.C. WainwrightSeptember 26, 2025 | msn.comFractyl Health (NASDAQ:GUTS) Price Target Lowered to $8.00 at HC WainwrightSeptember 26, 2025 | marketbeat.comFractyl Health, Inc. - Special CallSeptember 26, 2025 | seekingalpha.comFractyl Health says experimental procedure helps maintain weight-loss in studySeptember 26, 2025 | reuters.comFractyl Health Reveals Promising REMAIN-1 Study ResultsSeptember 26, 2025 | tipranks.comFractyl Health Prices $60 Million Underwritten Offering of Common StockSeptember 26, 2025 | quiverquant.comQFractyl Health Announces Pricing of $60 Million Underwritten Offering of Common StockSeptember 26, 2025 | globenewswire.comFractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 DiscontinuationSeptember 26, 2025 | globenewswire.comHC Wainwright & Co. Initiates Coverage of Fractyl Health (GUTS) with Buy RecommendationSeptember 16, 2025 | msn.comHC Wainwright Initiates Coverage on Fractyl Health (NASDAQ:GUTS)September 16, 2025 | marketbeat.comFractyl Health initiated with a Buy at H.C. WainwrightSeptember 15, 2025 | msn.comFractyl Health Inc News (GUTS) - Investing.comSeptember 7, 2025 | investing.comFractyl Health appoints Christopher Thompson, Ian Sheffield to boardSeptember 3, 2025 | msn.comFractyl Health Appoints New Directors Amid Leadership ChangesSeptember 3, 2025 | tipranks.comFractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic GrowthSeptember 3, 2025 | globenewswire.comLADENBURG THALM/SH SH Initiates Coverage on Fractyl Health (NASDAQ:GUTS)August 30, 2025 | marketbeat.comFractyl Health’s Earnings Call: Strategic Gains Amid Financial ChallengesAugust 14, 2025 | msn.comFractyl Health price target lowered to $6 from $12 at CanaccordAugust 14, 2025 | msn.comFractyl Health Reports Q2 2025 Financial Results and ProgressAugust 13, 2025 | msn.comFractyl Health, Inc. (GUTS) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comFractyl Health Announces Second Quarter 2025 Financial Results and Business UpdatesAugust 12, 2025 | globenewswire.com6GUTS : An Overview of Fractyl Health's EarningsAugust 12, 2025 | benzinga.comFractyl Health stock plunges after $20 million public offeringAugust 8, 2025 | investing.comFractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional SharesAugust 8, 2025 | finance.yahoo.comFractyl Health (GUTS) Projected to Post Quarterly Earnings on WednesdayAugust 7, 2025 | marketbeat.comFractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor ConferenceAugust 6, 2025 | globenewswire.comFractyl Health Announces Pricing of $20 Million Underwritten Public OfferingAugust 6, 2025 | globenewswire.comFractyl Health Sinks After-Hours On Stock Offering, But Investors Cheer Durable Weight Loss DataAugust 6, 2025 | msn.comFractyl Health, Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsAugust 5, 2025 | quiverquant.comQFractyl Health Announces Proposed Public OfferingAugust 5, 2025 | globenewswire.comFractyl Health Reports Potent and Durable Two-Year Real-World Outcomes with Revita® Showing Sustained Weight Loss and Improved Glucose Control After a Single ProcedureAugust 5, 2025 | globenewswire.comFractyl Health: Speculative Buy With Binary RiskJuly 16, 2025 | seekingalpha.comFractyl Health (NASDAQ:GUTS) Stock Price Up 2% - What's Next?July 10, 2025 | marketbeat.comFractyl Health Reports 3-Month REVEAL-1 Data Suggesting Durable Weight Maintenance, Stock Down - NasdaqJune 25, 2025 | nasdaq.comPromising Data from Fractyl Health’s Reveal-1 Study Boosts Confidence in Revita Treatment Ahead of Pivotal Remain-1 StudyJune 25, 2025 | tipranks.comFractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita® Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance TherapyJune 23, 2025 | globenewswire.com Get Fractyl Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GUTS Media Mentions By Week GUTS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GUTS News Sentiment▼1.120.55▲Average Medical News Sentiment GUTS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GUTS Articles This Week▼83▲GUTS Articles Average Week Get the Latest News and Ratings for GUTS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Fractyl Health and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Brainsway News Sanara MedTech News Outset Medical News Monogram Orthopaedics News Shoulder Innovations News Inogen News TriSalus Life Sciences News CVRx News Nano-X Imaging News CapsoVision News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GUTS) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | SponsoredGOLD ALERTGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fractyl Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fractyl Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
